Related Articles
Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up
Immunoregulatory therapy strategies that target cytokine storms in patients with COVID‑19 (Review)
Can mesenchymal stem cells be used to treat COVID‑19‑induced pneumonia? (Review)
Effective remission of an elderly patient with refractory atopic dermatitis and foot ulcers following infusion with human umbilical cord‑derived mesenchymal stem cells: A case report
Long‑term effects of COVID‑19 in sickle cell disease: A case report